4//SEC Filing
Vardeman Ryan L. 4
Accession 0000899243-20-007881
CIK 0001054721other
Filed
Mar 10, 8:00 PM ET
Accepted
Mar 11, 4:05 PM ET
Size
23.8 KB
Accession
0000899243-20-007881
Insider Transaction Report
Form 4
BSQUARE CORP /WABSQR
Vardeman Ryan L.
Director
Transactions
- Purchase
Common Stock, No Par Value
2020-03-09$1.20/sh+35,787$42,934→ 1,420,315 total(indirect: See Footnotes) - Purchase
Common Stock, No Par Value
2020-03-10$1.18/sh+32,900$38,733→ 1,453,215 total(indirect: See Footnotes)
Holdings
- 51,389
Common Stock, No Par Value
Transactions
- Purchase
Common Stock, No Par Value
2020-03-09$1.20/sh+35,787$42,934→ 1,420,315 total(indirect: See Footnotes) - Purchase
Common Stock, No Par Value
2020-03-10$1.18/sh+32,900$38,733→ 1,453,215 total(indirect: See Footnotes)
Holdings
- 51,389
Common Stock, No Par Value
Transactions
- Purchase
Common Stock, No Par Value
2020-03-10$1.18/sh+32,900$38,733→ 1,453,215 total(indirect: See Footnotes) - Purchase
Common Stock, No Par Value
2020-03-09$1.20/sh+35,787$42,934→ 1,420,315 total(indirect: See Footnotes)
Holdings
- 51,389
Common Stock, No Par Value
Transactions
- Purchase
Common Stock, No Par Value
2020-03-10$1.18/sh+32,900$38,733→ 1,453,215 total(indirect: See Footnotes) - Purchase
Common Stock, No Par Value
2020-03-09$1.20/sh+35,787$42,934→ 1,420,315 total(indirect: See Footnotes)
Holdings
- 51,389
Common Stock, No Par Value
Footnotes (7)
- [F1]This price represents the approximate weighted average price per share of common stock of BSQUARE Corporation, a Washington corporation (the "Issuer"), no par value ("Shares"), of purchases that were executed at prices ranging from $1.192 to $1.20 per Share. The reporting persons undertake to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the price per Share and the number of Shares purchased at each price.
- [F2]This statement is jointly filed by and on behalf of each of Ryan L. Vardeman, Palogic Value Fund, L.P., a Delaware limited partnership ("Palogic Value Fund"), Palogic Value Management, L.P., a Delaware limited partnership ("Palogic Value Management"), and Palogic Capital Management, LLC, a Delaware limited liability company ("Palogic Capital Management"). Mr. Vardeman and Palogic Value Fund are the record and direct beneficial owners of the securities covered by this statement. Palogic Value Management is the general partner of, and may be deemed to beneficially own securities owned by, Palogic Value Fund. Palogic Capital Management is the general partner of, and may be deemed to beneficially own securities beneficially owned by, Palogic Value Management.
- [F3](Continued from Footnote 2) Mr. Vardeman is the sole member of, and may be deemed to beneficially own securities beneficially owned by, Palogic Capital Management. Mr. Vardeman is also a limited partner in, and may be deemed to beneficially own securities owned by, Palogic Value Fund.
- [F4]The reporting persons state that neither the filing of this statement nor anything herein shall be deemed an admission that the reporting persons are, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") or otherwise, the beneficial owners of any securities covered by this statement. The reporting persons disclaim beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of the reporting persons in such securities.
- [F5]The reporting persons may be deemed to be a member of a group with respect to the Issuer or securities of the Issuer for purposes of Section 13(d) or 13(g) of the Exchange Act. The reporting persons declare that neither the filing of this statement nor anything herein shall be construed as an admission that such persons are, for the purposes of Section 13(d) or 13(g) of the Exchange Act or any other purpose, a member of a group with respect to the Issuer or securities of the Issuer.
- [F6]This price represents the approximate weighted average price per Share of purchases that were executed at prices ranging from $1.17 to $1.18 per Share. The reporting persons undertake to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the price per Share and the number of Shares purchased at each price.
- [F7]Includes 8,680 restricted stock units of the Issuer awarded to Ryan L. Vardeman on June 11, 2019, pursuant to the Issuer's compensation plan for non-employee directors and the Fourth Amended and Restated Stock Plan of the Issuer which have not yet vested.
Issuer
BSQUARE CORP /WA
CIK 0001054721
Entity typeother
Related Parties
1- filerCIK 0001574629
Filing Metadata
- Form type
- 4
- Filed
- Mar 10, 8:00 PM ET
- Accepted
- Mar 11, 4:05 PM ET
- Size
- 23.8 KB